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Context: Globally, the use of alcohol is a leading cause of mortality and morbidity. Oppor-
tunistic screening and brief interventions (SBIs) have been shown to be effective in reducing 
alcohol consumption in certain primary care settings and provide a means of reaching some of 
those who do not seek treatment for alcohol-related problems. Further, community pharmacies 
have the potential to reach consumers at an early stage of their alcohol use and incorporate 
intervention and advice into their role in providing medications.
Aim: The purpose of this review was to inform pharmacists and stakeholders of the evidence 
base for SBI in community pharmacy settings. To date, there has been limited research on the 
effectiveness of alcohol SBI in community pharmacies, with a systemic review only identifying 
two randomized trials.
Methods: This narrative review reports on the period 2007–2017, covering feasibility studies, 
pilot programs, and surveys of consumers and pharmacy staff attitudes relating to alcohol SBI 
in this setting. Studies were identified via MEDLINE, CINAHL, Google Scholar, and reference 
lists of relevant publications.
Findings: The findings indicated that the provision of community pharmacy alcohol SBI requires 
training in communication and intervention skills and in some cases increasing confidence 
and alcohol-related knowledge. Consumers were generally receptive to the SBI approach but 
requested private areas for delivery of such.
Conclusion: The high prevalence of “at risk” alcohol use in many countries and the low level 
of treatment seeking by this group means that novel approaches to engage opportunistically 
with these people is imperative in reducing alcohol-related harms. However, before committing 
routine health funding, these novel approaches need rigorous evaluation.
Keywords: alcohol, brief intervention, screening, community pharmacy, review, primary care
Introduction
Alcohol is a leading cause of preventable harm internationally, in 2012, causing 3.3 
million deaths and the loss of 139 million disability-adjusted life years or 5.1% of 
global disease burden.1 Due to its prevalence, risky or subclinical levels of drinking are 
responsible for more harms than alcohol-use disorders.2,3 However, few people using 
alcohol in a risky manner, or even those with an alcohol disorder, seek help.4–6 The 
provision of alcohol advice, for example, provided through opportunistic screening 
and brief intervention (SBI), has proven successful in primary care settings in reduc-
ing alcohol consumption and alcohol-related harms.7 This creates an opportunity for 
community pharmacies, as pharmacy staff have regular contact with consumers who 
have health conditions caused or exacerbated by alcohol use. Community pharmacists 
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are thus well placed to provide alcohol-misuse services and 
support.
The hazardous and harmful use of alcohol had been clas-
sified by the World Health Organization (WHO) as one of 
the most important risks to health.8 The 2014 WHO report 
Global Status Report on Alcohol and Health confirmed that 
risky alcohol consumption is problematic in both developed 
and developing countries.1 For example, in Australia, alcohol 
consumption is estimated to cause 3.2% of the total burden 
of disease. Including harms to nonusers, it contributes about 
188,000 disability-adjusted life years, causes 5,550 deaths, 
and costs ~AU$30 billion per year.9,10 Australian guidelines 
provide recommendations for the adult population to reduce 
the risk of alcohol-related harm.11 Still, considered against the 
guidelines, in 2016, about 17% of adults were “at-risk” from 
their average alcohol consumption (more than two standard 
drinks per day), about 26% from single occasion use (more 
than four standard drinks at an occasion), and 37% from 
either single occasion or average use.12 Further, about 3.9% 
and 1.4% of the population fulfill the criteria for an alcohol 
disorder (harmful use or dependence)13 (see Box 1).
Alcohol use is implicated in a wide range of conditions, 
including cardiovascular disease, many cancers, diabetes, 
overweight, and obesity.11 Previous assumptions that mod-
erate alcohol use was protective for some conditions, in 
particular cardiovascular disease, is now suggested to be an 
artifact of observational studies.14 Opportunistic screening 
can be used to identify those “at risk” of alcohol-related 
harms, and universal screening is recommended in primary-
care settings and emergency departments.2
Community pharmacy staff are often the first point of con-
tact for consumers accessing the health-care system.15 Phar-
macy staff regularly assist consumers with the  management 
of minor, self-limiting symptoms16,17 that could be associated 
with inappropriate alcohol use (ie, indigestion, vomiting, 
diarrhea, headaches, sleeping irregularities, requests for 
hangover management).18 Requests for emergency contra-
ception also provide an opportunity to explore alcohol use.19 
Additionally, pharmacists have regular contact with consum-
ers with chronic conditions through the dispensing of repeat 
prescriptions to manage these conditions.20,21
Community pharmacists are thus well placed to play a 
role in the early intervention process through provision of 
alcohol-misuse services, such as SBI and provision of ongo-
ing support. Pharmacists and pharmacy staff have the oppor-
tunity to identify consumers who may have risky drinking 
behaviors, with the potential to educate them about alcohol 
use. This presents a unique opportunity for community 
pharmacists to discuss alcohol-related matters, illness, and 
relevant social issues with consumers and provide informa-
tion and facilitate referrals. The WHO report on strategies 
for implementing early identification and alcohol-focused 
interventions in primary health care emphasized the variety of 
locations in which alcohol services, such as brief intervention 
(BI), can be provided.22 Community pharmacy staff are in an 
ideal situation to complement services provided by general 
practitioners (GPs) or hospital emergency departments and 
contribute to alcohol awareness.
Objective
A recent systematic review and meta-analysis of community 
pharmacy interventions for smoking cessation, weight man-
agement, and alcohol reduction identified only two studies 
addressing alcohol use that fulfilled their inclusion criteria.23 
The objective of this review was to identify and evaluate the 
broader available literature on community pharmacy alcohol-
misuse services.
Methods
This narrative literature review provides a summary of the 
role of community pharmacists in addressing alcohol misuse 
through integration with other professional activities. This 
is followed by a review of the literature on the role of com-
munity pharmacists in alcohol intervention studies. This 
review also provides an overview of key alcohol SBI studies.
The review of the role of community pharmacists in 
alcohol intervention studies involved searching CINAHL, 
Medline, and Google Scholar for the period 2007–2017 using 
the search terms “alcohol”, “alcohol misuse”, “alcohol inter-
vention”, and “community pharmacy” to identify articles on 
the role of pharmacists in alcohol-misuse services. Literature 
Box 1 Common alcohol terminology
1. Risky drinking: a specific term for a pattern or level of drinking 
associated with increased risk of alcohol-related harms
2. Hazardous use: currently used by the World Health Organization 
(but not a diagnostic category) to denote a pattern of use that 
increases the risk to the user; most notably used in the Alcohol Use 
Disorders Identification Test (AUDIT) for those scoring ≥8 or more
3. Harmful use: International Classification of Disease (ICD)-10 
diagnosis where use is causing social, physical, or mental harms
4. Dependent use: ICD-10 diagnosis that requires three or more 
criteria to be fulfilled (eg, tolerance, inability to control use, 
compulsion to use, withdrawal state, preoccupation with use, and 
use despite harms)
5. Dependent use: DSM5-classified as mild, moderate, or severe, 
depending on the number of symptoms present
Note: Data from the World Health Organization100,101 and the American Psychiatric 
Association.102
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on the role of community pharmacists in alcohol-intervention 
studies focused on reports published after 2007: the inter-
val since the last systematic review focused specifically on 
alcohol services in community pharmacies.24 Studies that 
involved pharmacists in other settings (ie, hospital pharma-
cies) were excluded. As searching of databases resulted in a 
limited number of studies, a snowballing process was also 
followed, whereby the reference lists of relevant articles were 
scanned to identify more publications. Gray literature was 
also identified through generic search engines.
This narrative review was undertaken in the context of the 
WHO report on strategies for implementing early interven-
tion at the primary health level,22 the changing landscape of 
community pharmacy with regard to the provision of patient 
care services and chronic disease management,25 and commu-
nity pharmacists being ideally positioned to provide support 
to consumers with mental health illness, including alcohol 
misuse, at the primary health-care level.26
Results
Role of community pharmacists in 
addressing alcohol use
Pharmacists have regular contact with consumers with 
chronic conditions through dispensing services, which 
provide opportunities to screen and educate them about 
various health-related issues, including alcohol use. Certain 
medical conditions, such as peptic ulcer disease and diabetes, 
require an understanding of the risks involved with alcohol 
consumption, such as increased risk of ulcer bleeding and 
hypoglycemia.1,27 Long-term harmful drinking may contrib-
ute to the development of chronic conditions, such as car-
diovascular disease, cirrhosis of the liver, dementia, mental 
health problems, and cancer.28 Of specific relevance is the 
comorbidity or the co-occurrence of alcohol-use disorders 
and other mental disorders, which can be a major challenge 
in treating either problem.29 For example, the seminal US 
Epidemiologic Catchment Area study found that among 
those with an alcohol disorder, the lifetime prevalence of 
any (nonsubstance use) mental health disorder was 36% 
(OR 2.3 compared to those without an alcohol disorder).30 
In Australia, ~35% of those with a substance-use disorder in 
the previous 12 months also had another mental disorder,31 
with a 2014 Australian Institute of Health and Welfare report 
indicating 31.1 million government-subsidized mental health 
prescriptions dispensed in 2012–2013, accounting for 11.4% 
of all prescriptions.21
Medication interactions with alcohol are particularly 
risky in older adults, due to the high incidence of multiple 
comorbidities, physiological changes,32,33 and increased risk 
of falls.34 Certain medicines are specifically contraindicated 
with alcohol and can cause a disulfiram-type reaction (ie, 
metronidazole) or falls due to increased drowsiness, eg, 
certain antipsychotics, hypnotics, and opioid analgesics.27 
Pharmacists should attach cautionary advisory labels when 
dispensing and counsel consumers about the impact of alco-
hol on their medicines.18 However, despite these issues, a 
2005 Australian survey of 816 adults showed that concurrent 
use of medicines and alcohol was common.35 A more recent 
survey of 188 adults aged 60–89 years showed that very few 
recalled a discussion with their pharmacists in the previous 
12 months about alcohol use, but much higher percentages 
recalled discussions with their GPs.36 Of significance was that 
50% of the men and 63% of the women believed it appropriate 
for pharmacists to ask about alcohol use, showing a need to 
increase community pharmacists’ awareness of the need to 
discuss alcohol use with consumers.
Community pharmacists provide a wide range of primary 
health-care services and interventions,20,37–39 with research 
showing positive consumer health outcomes.40–44 Trials and 
observational studies have provided evidence of the clinical 
efficacy and cost-effectiveness of community pharmacy-led 
smoking cessation23 and lipid management interventions in 
the reduction of risky behaviors and risk factors for coronary 
heart disease.45 There is also evidence for positive outcomes 
when pharmacists support consumers with mild–moderate 
mental illnesses.46
The positive impact of pharmacist interventions to assist 
consumers with smoking cessation47–49 has resulted in many 
pharmacies providing smoking cessation advice as part of 
normal practice. A scoping review about the role of com-
munity pharmacists in public health identified a wide range 
of services provided, with one of the dominant themes being 
prevention of drug-related problems and addiction.50 A study 
among the general public in the UK showed people were 
receptive to pharmacy public health services.51 However, 
the role of community pharmacy in public health promotion 
seems to be underutilized in some countries,52 and a specific 
need has been identified to include community pharmacies as 
part of strategies to address excessive alcohol use.24
Targeted community pharmacy alcohol-
misuse services
The role of the community pharmacy in provision of alcohol 
services is new compared with other professional services. 
Only two systematic reviews were identified about the 
effectiveness of community pharmacy alcohol interven-
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tions. A review conducted by Watson and Blenkinsopp that 
incorporated the period 1996–2007 identified three feasibility 
studies involving 14 pharmacies and 500 customers.24 The 
authors concluded that there was little empirical evaluation 
of the impact of community pharmacy–based alcohol-misuse 
services and that large-scale studies were needed. A more 
recent systematic review by Brown et al that included articles 
up to May 2014 about the effectiveness of community phar-
macy–delivered interventions for alcohol reduction, smoking 
cessation, and weight management identified two randomized 
controlled trials (RCTs) on community pharmacy alcohol-
reduction interventions.23 Both these RCTs were conducted in 
the UK, with Watson et al53 using the Fast Alcohol Screening 
Tool, whereas Dhital et al54 used the Alcohol Use Disorders 
Identification Test (AUDIT). The studies involved 36 phar-
macies and 476 customers. Evidence about the impact of the 
pharmacist interventions from both studies was limited, and 
the authors recommended that further research was required 
on the cost-effectiveness of community pharmacy-delivered 
alcohol-misuse services.
In addition to the RCTs identified in the Brown et al 
review, a number of other recent (post-2007) studies have 
focused on the feasibility, effectiveness, and acceptability of 
community pharmacy–based alcohol-misuse services from 
both consumers’ and pharmacists’ perspectives. Identified 
studies were conducted in the UK and New Zealand (NZ) 
and more recently in Australia. Table 1 provides a summary 
of these studies.
A study by Sheridan et al that involved a survey of 2,384 
NZ pharmacy consumers from 43 pharmacies showed posi-
tive consumer attitudes to pharmacists undertaking SBI, with 
~30% of participants with at-risk drinking who could benefit 
from a pharmacy intervention.55 Research by Fitzgerald et al 
based in Scotland, which involved a 2-day training course of 
22 pharmacy staff from the Greater Glasgow area in alcohol 
screening and intervention, recruited 70 consumers, with 
30 screened as drinking hazardously and seven at harmful 
levels.56 Consumers received such interventions as explana-
tion of “low-risk” drinking, feedback on screening, and risks 
to health. On follow-up, consumers were generally positive 
about the pharmacy intervention, and pharmacists perceived 
the project as worthwhile.57 A study by Brown et al in North 
East England that focused on women who accessed com-
munity pharmacies for emergency contraception showed that 
some pharmacists felt uncertain about engaging consumers 
in conversations about sensitive topics, although interviews 
with the consumers themselves showed that they were not 
embarrassed, appreciated receiving advice, and felt that a 
pharmacist was an appropriate person to carry out alcohol 
screening and provide advice.58
Dhital et al have been involved in a number of studies 
in the UK. A 2008 London study with 237 participants 
from four pharmacies indicated high consumer willingness 
to participate in SBI and follow-up appointments with the 
pharmacist.59 Pharmacists were considered more acces-
sible to the public than GPs, although there were concerns 
whether pharmacists were knowledgeable or had suitable 
training to conduct SBI. The London researchers conducted 
a subsequent pre and postexperimental study involving 141 
consumers from 26 community pharmacies, during which 
75% of the participants were identified as risky drinkers. 
Three-month follow-up interviews with hazardous drinkers 
found that they significantly reduced their alcohol consump-
tion and drinking days, although there was no difference 
in AUDIT-C (alcohol-consumption questions from the full 
AUDIT) scores.60 The results from this study were used to 
design a two-arm RCT.61 However, the RCT conducted in 
London between May 2012 and May 2013 that involved 
407 pharmacy consumers did not show any difference at 
3-month follow-up between the intervention (n=205) and 
control (n=202) groups in terms of drinking behavior. The 
authors concluded that the pharmacists were undertrained in 
delivering BIs, as they had only received 3.5 hours of training, 
and it was hence recommended that training should be more 
comprehensive and incorporate communication approaches 
and motivational interviewing.54
Another UK study by Krska and Mackridge62 conducted 
in North West England involved interviewing 150 consum-
ers about their perspectives on community pharmacy–based 
alcohol services. A focus group was subsequently conducted 
to obtain input into the design of an alcohol SBI pilot study. 
Five pharmacies screened 164 consumers over a 2-month 
period using AUDIT. Of those consumers, 113 were low-
risk, 24 increased-risk, and 28 high-risk/possibly dependent 
drinkers. Ten of the service users interviewed considered the 
experience positive but wanted the service to be delivered 
in a private area.
A Western Australian feasibility study by Hattingh et al 
conducted toward the end of 2014 involved five community 
pharmacies in Perth enrolling and screening 50 consumers 
in total.63 Pharmacists already had motivational interview-
ing skills,46 and two pharmacists at each pharmacy received 
face-to-face training in alcohol SBI by an experienced phar-
macist who also acted as a mentor throughout the project. 
From the consumers’ AUDIT scores, 11 were categorized 
as “hazardous” (score 8–15), 4 as “harmful” (score 16–19), 
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and 8 as “probably dependent” (score 20+) consumers of 
alcohol. Those scoring ≥8 received brief advice and an 
alcohol information booklet.64 Reactions to the SBI process 
were generally favorable, and a post-SBI consumer question-
naire showed that 75% agreed that it was either appropriate 
or very appropriate for the pharmacist to ask about their 
alcohol consumption and 88% reported being comfortable 
discussing their alcohol consumption with the pharmacist. 
Semistructured interviews with 10 participating pharma-
cists indicated that alcohol SBI was manageable within the 
community pharmacy setting and fitted well within the 
scope of practice. The majority commented that AUDIT was 
helpful as a screening tool and that it aided in initiating a 
discussion on the customer’s alcohol use.
A study by Sheridan et al that surveyed NZ pharmacists 
showed that their knowledge of alcohol content of alcoholic 
Table 1 Overview of community pharmacy alcohol-misuse intervention studies
Study design Short description of research Country References
Focus groups Two focus groups conducted with 14 community pharmacists. Participants 
acknowledged alcohol advice as part of role but identified need to increase knowledge, 
skills, and confidence
Australia Dare et al67
Mixed methods: 
survey and 
interviews
Five pharmacies provided SBI to 50 consumers who completed AUDIT. Post-SBI 
survey and 3-month follow-up interviews showed acceptability of service. Ten 
pharmacists interviewed were positive about service
Australia Hattingh et al63
Survey One hundred and eighty-eight people aged >60 years responded. 50% of men and 
65% of women were receptive to having alcohol-related health conversations with 
community pharmacists
Australia Wilkinson et al36
Randomized 
controlled trial
Parallel group randomized trial involved 16 community pharmacies and 407 pharmacy 
customers in London. Customers completed AUDIT; those who scored 8–19 were 
allocated to SBI or leaflet. At 3 months, 326 participants were followed up. SBI 
appeared to have no effect, and follow-up interactions recommended
UK Dhital et al54
Mixed methods: 
interviews, 
focus group, and 
observation
Face-to-face survey of 150 consumers about pharmacy-based alcohol services 
incorporated FAST. Nine participants of focus group to design a service. Five 
pharmacies participated in 2-month pilot of 164 screenings, with 15% AUDIT score of 
increased risk, 12% high risk, and 5% possibly dependent
UK Krska and Mackridge62
Interviews Clients requesting emergency contraception completed AUDIT: 22 clients identified as 
“low risk” interviewed were positive about service; most of 53 in “risky” category felt 
advice was useful and appropriate to be provided by a pharmacist
UK Brown et al58
Mixed methods: 
survey and 
interviews
Twenty-six community pharmacies provided SBI to 141 consumers who completed 
AUDIT-C. Follow-up interviews with 61 hazardous/low-risk drinkers showed 
significant reduction in 7-day alcohol-unit consumption, but not AUDIT-C scores
UK Khan et al60
Survey Cross-sectional, anonymous survey through 43 randomly selected NZ community 
pharmacies. 2,384 consumers completed AUDIT-C, with 30% considered risky 
drinkers. Attitudes to pharmacy SBI were generally positive
NZ Sheridan et al55
Interviews Interviews with 22 English and 18 NZ pharmacists. Pharmacists were mostly positive 
about pharmacy SBI. Barriers and facilitators identified
NZ and UK Horsfield et al68
Survey Survey of all community pharmacies in Scotland, with 45% (487 of 1,098) response 
rate. Knowledge of recommended alcohol-intake limits was high (84%), but few (5%) 
advised consumers on alcohol consumption. Approximately 25% were confident in 
providing SBI. Mixed views on appropriateness of pharmacy-based SBI services
UK McCaig et al66
Interviews Interviews with pharmacists from 43 NZ pharmacies that handed out surveys to 
customers about alcohol use and pharmacy SBI services
NZ Sheridan et al69
Mixed methods: 
survey and 
interviews
Purposive sampling to select four London pharmacies. 237 consumers approached, 89 
completed AUDIT-C, 51 (52%) identified as risky drinkers, 97 (96%) willing to discuss 
drinking, and 99 (98%) to accept information
UK Dhital et al59
Interviews Nine pharmacists and 13 assistants trained over 2 days. They were positive about 
training
UK Fitzgerald et al57
Survey Postal survey of community pharmacies, with 39.1% response rate. Participants’ 
general knowledge of alcohol content of drinks and recommended safe-drinking limits 
was poor, but they were motivated to undertake an SBI role
NZ Sheridan et al65
Mixed methods: 
survey and 
interviews
They recruited 70 clients over 3 months. FAST used to screen and guide the 
intervention: 30 screened as drinking hazardously (42.9%) and seven (10%) positive for 
harmful drinking; 19 at 3-month follow-up positive about the experience
UK Fitzgerald et al56
Abbreviations: SBI, screening and brief intervention; AUDIT-C, Alcohol Use Disorders Identification Test —consumption (items 1–3 from AUDIT); FAST, Fast Alcohol 
Screening Tool; NZ, New Zealand.
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drinks and recommended “low-risk” drinking limits was 
poor, although participants were keen to take on a role in 
alcohol SBI.65 The study highlighted a need for pharmacy-
staff training prior in delivering a pharmacy SBI service. A 
postal survey by McCaig et al to characterize community 
pharmacists’ level of activity and views on alcohol-misuse 
services sent to all community pharmacies in Scotland 
achieved a 45% (497 of 1,098) response rate.66 Although 
the pharmacists’ knowledge of recommended alcohol-
intake limits was high, few advised consumers on alcohol 
consumption. About 40% lacked confidence in providing 
alcohol SBI, and they had mixed views on the appropriate-
ness of pharmacist involvement in discussing alcohol use 
with consumers. Dare et al reported a 2014 focus group study 
with Perth community pharmacists and found they regarded 
the provision of alcohol advice as part of a pharmacist’s 
role that could be linked to other professional services, 
such as dispensing.67 However, lack of knowledge, skills, 
confidence in how to approach consumers, and discussing 
alcohol use in a nonconfrontational way were identified as 
barriers, and highlighted a need for specific alcohol-related 
communication-skill training to be able to raise consumers’ 
alcohol use in a nonconfrontational manner. Other barriers 
identified were time and financial constraints, similar to 
previous research by Horsfield et al.50,68
Research in NZ and England regarding SBIs with problem 
drinkers indicated that pharmacists considered there was 
scope for alcohol-related health promotion in community 
pharmacies.68,69 Participants identified a need for appropriate 
screening tools and training, whereas barriers to community 
pharmacy SBIs included concerns about offending or alienat-
ing consumers, lack of experience or confidence, workforce 
pressures, privacy, and remuneration.
Only one of the identified reports used a “strong” study 
design (RCT)54 to assess behavioral outcomes, and it reported 
no significant effect on alcohol measures at 3 months. In 
contrast, the remaining 14 studies that addressed more 
distal issues, such as consumer attitudes and feasibility, 
were generally positive. Further, these studies showed that 
community pharmacists were willing to deliver alcohol SBI 
and advice, but needed to receive relevant training beyond 
alcohol guidelines that specifically incorporated communi-
cation strategies. Overall, the evidence suggests that SBI in 
community pharmacies is feasible, with positive feedback 
from consumers, but until interventions are developed that are 
effective in reducing alcohol-use or alcohol-related harms, 
it is premature to advocate for their funding.
Alcohol-use screening tools
There are no validated biomarkers of risky drinking: even 
among those with an alcohol disorder, biological measures, 
such as liver function tests, while commonly used clinically, 
have poor screening characteristics.70 Therefore, risky drink-
ers need to be identified with self-report measures.
The most widely used and extensively validated measure 
of this type is the 10-item AUDIT.71 This was developed by 
the WHO and has been validated as a screening tool in a 
range of adult populations. Scores >7 are used to identify 
those with hazardous or harmful levels of alcohol use. Those 
scoring ≥8 are considered to be “at-risk” of alcohol-related 
harms. Those scoring ≥20 are likely to have an alcohol-use 
disorder. It is generally accepted that BIs are less effective for 
this group,72 and that they should be advised to seek specialist 
help or speak to their GP.
AUDIT-C is a validated abbreviated version of the AUDIT 
consisting of the first three items of the AUDIT73,74 to quickly 
identify those engaged in “risky” alcohol use (females ≥3, 
males ≥4). Those fulfilling these criteria should then complete 
the remaining AUDIT questions. There have been numerous 
other alcohol (and other drug)-screening instruments that 
have been developed.75 Details of the screening character-
istics and the target populations of 14 leading instruments 
have been published by the National Institute on Alcohol 
Abuse and Alcoholism, and the report is freely available to 
the public.76
Screening and brief alcohol interventions
A review of reviews identified 24 systematic reviews of alco-
hol SBI in primary care,7 and highlighted the extensive data 
on their effectiveness, particularly for middle-aged men and 
those with subclinical levels of use. Table 2 is a summary of 
key research on the topic of SBI for problematic alcohol use 
in primary care, showing a number of systematic reviews that 
have been conducted over an extended period. It incorporates 
the aforementioned review of reviews and also an economic 
evaluation. Despite the evidence supporting SBI in general 
practice, many GPs do not routinely assess patients for risky 
drinking or provide advice to high-risk groups.77,78 Provid-
ing alcohol SBI in community pharmacies thus offers an 
alternative primary health-care setting in which to address 
alcohol-misuse and health-related issues.
As already noted, those with an alcohol disorder are 
generally referred for intensive intervention. Those with less 
severe problems are more likely to have intact psychosocial 
supports and do not generally require the resource-intensive 
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interventions usually needed by those with alcohol depen-
dence. Therefore, identifying and managing people before 
they develop major physical and/or psychosocial complica-
tions is desirable, and the identification of risky alcohol-use 
consumers is a major goal for SBI.79 In addition, opportunistic 
SBI may reach a proportion of those who would not normally 
seek help or present at specialist treatment facilities.
There is no universally accepted definition of what con-
stitutes a BI, but one or two sessions of treatment is typical.80 
Within a primary care setting, interventions can be incorpo-
rated within a 5- to 15-minute consultation.81 Box 2 lists five 
key elements that have been identified for inclusion in an 
intervention.82 Similarly, the components of a BI have been 
summarized with the acronym FRAMES (personally relevant 
feedback, client’s responsibility for change, objective advice, 
menu of options, empathic, nonconfrontational approach, and 
self-efficacy in the client to change their behavior). In addition, 
these components draw on principles of motivational inter-
viewing, such as empathy, creating ambivalence, rolling with 
resistance, and reflective listening. Typically, BIs have a goal 
of harm reduction, rather than abstinence, except where clini-
cally indicated (eg, pregnancy, medication interaction).72,83
Discussion
This narrative review has identified a number of studies 
that evaluated community pharmacy–delivered alcohol SBI 
services. Overall consumer attitudes toward community 
pharmacy alcohol SBI was positive, although some stud-
ies identified a consumer need to increase privacy in the 
pharmacy setting. Pharmacists reported that it was feasible 
to deliver interventions in this environment, but highlighted 
training requirements that incorporate communication 
aspects and specific alcohol information. Over the  previous 
10 years, there have only been two RCTs to evaluate the 
ongoing impact of community pharmacy SBI services, both 
of these in the UK. Evidence about the impact of pharma-
cists’ interventions from both studies were limited, and 
further research is thus needed to evaluate the effectiveness 
and cost-effectiveness of community pharmacy–delivered 
alcohol-misuse services.
The need to increase privacy was raised in some of the 
alcohol SBI studies, which is similar to literatures that high-
lighted community pharmacy privacy needs.84,85 However, 
newer professional services in many countries now require 
and in some instances mandate pharmacies to have private 
areas, eg, England and Wales pharmacies prior to 2005 had 
already required consultation rooms for advanced services86 
and Australian community pharmacies since 2012 have 
needed to have a private area to offer government-reimbursed 
in-pharmacy medication-review services87 and pharmacist-
administered influenza-vaccination services.88,89 This space 
is also used to discuss confidential and sensitive issues with 
consumers90 and conduct screening services (ie, blood pres-
sure measurements) and could be used for SBI and provision 
of alcohol-related services.
Table 2 Key alcohol-screening and brief intervention studies in primary health care
Study type Short description of research References
Systematic review of 
reviews
2002–2012: 24 systematic reviews of 56 trials of SBI in primary care. Extensive evidence supported 
benefit for middle-aged males with at-risk drinking: fewer data on other groups
O’Donnell et al7
Clinical guideline Task force recommended that clinicians screen adults for alcohol misuse and provide risky drinkers 
with brief behavioral counseling interventions
Moyer103
Cost-effectiveness Model costs of screening all new registrations with family doctors and at next appointment. Both 
approaches were cost-effective, eg, saving of £120 m over 30 years or £6,900/QALY gained
Purshouse et al104
Systematic review Review of 22 trials (n=7,619): those receiving SBI had significantly lower alcohol use at 12 months, 
but not successful with the smaller subgroup of eight trials reporting outcomes by sex
Kaner et al105
Systematic review Nineteen trials (n=5,639) showed mean reduction of 38 g alcohol per week for SBI compared with 
controls, with benefits for both males and females at 6 and 12 months
Bertholet et al106
Systematic review Thirty-four trials with nontreatment-seeking people. Effect sizes at 3 months of SBI versus control: 
composite measure, d=0.30; alcohol consumption, d=0.67
Moyer et al72
Abbreviations: SBI, screening and brief intervention; QALY, quality-adjusted life year.
Box 2 Five key elements identified for inclusion in an intervention
1. Assess the quantity and frequency of alcohol usage and provide 
direct feedback regarding health or psychosocial morbidity 
relevant to the client
2. Goals for alcohol use are established that are acceptable to both 
the provider and the client. These goals may be a reduction in 
consumption, such as using alcohol in a “low-risk” fashion or 
complete cessation
3. The provider uses behavioral modification techniques, eg, to help 
the client identify high-risk situations and develop strategies to 
deal with these
4. The provider should supply support material on problems 
associated with alcohol use plus self-help techniques
5. The provider should offer ongoing support
Note: Data from Humeniuk et al.82
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The role of community pharmacists in the provision 
of ongoing support for consumers with mental illness is a 
growing service, with evidence showing positive consumer 
impact.91,92 Delivering support for mental health consumers 
through community pharmacies has revealed that trusting 
relationships among consumers, carers, and pharmacy staff 
underpin perceptions of the pharmacy as a safe health space 
where consumers feel comfortable sharing personal informa-
tion,44 with positive consumer outcomes.46 Alcohol misuse 
is classified as a mental health condition93 and thus sits well 
with the role that community pharmacists play in terms of 
screening as well as disease state management services. Com-
munity pharmacists are thus in an ideal position to provide 
alcohol SBI and support.
Community pharmacies provide accessible and affordable 
health care, while consumers have control over the level of 
engagement with the staff.37 Research has demonstrated that 
the public see pharmacists as trustworthy medicine experts 
and reliable advisors on health matters with collaborative 
relationships with the medical profession.37,44,94 From a 
consumer perspective, an Australian study that involved 
intervention preferences of rural communities showed that 
community pharmacy alcohol interventions were indeed 
acceptable.95 Community pharmacy alcohol services could 
thus particularly benefit rural and remote populations.
Appropriate training to equip pharmacists with knowl-
edge to conduct alcohol SBI that also provides skills in 
advanced communication aspects, such as motivational 
interviewing, was identified by pharmacists in several 
studies.54,65,67 Any alcohol intervention study should thus 
incorporate training to ensure pharmacists are confident in 
the provision of the service. Lessons could be used from 
other studies that evaluated the training of pharmacists in 
motivational interviewing to address other behavior changes, 
such as smoking cessation47–49 and weight management,39 
that incorporated behavioral therapy/modification with posi-
tive results. Other community pharmacy interventions have 
shown positive behavior change results for diabetes, asthma, 
and cardiovascular disease through the use of repeated assess-
ment, management, monitoring, and review.96–98
Even though there is a strong evidence base for the 
use of SBI in primary care settings,7 when a person scores 
below the screening threshold, pharmacy staff should 
also include additional information they already hold or 
can observe about that person (eg, current mediations, 
pregnancy status, other health issues) in deciding if an 
intervention is warranted. However, it is important not to 
use stereotypes of potential at-risk drinkers in targeting 
customers for screening. Nevertheless, where compre-
hensive screening is not feasible, some studies have used 
requests for key medications as a means of increasing the 
yield from screening and as a way of starting a discussion 
about lifestyle factors, including alcohol use.63
This review focused on the role of community pharma-
cists in alcohol intervention studies. The strength of this 
review lies in it being a comprehensive review of topics 
amid the lack of RCTs about the impact of community 
pharmacy alcohol SBI services. However, as this is a nar-
rative rather than a systematic review, it is possible that 
not all studies on community pharmacy alcohol services 
were incorporated.
Conclusion
The literature provides some evidence to support the 
potential role of community pharmacy alcohol interven-
tions. However, a critical consideration at this stage is that 
neither of the two RCTs on the topic reported reductions 
in alcohol measures to support their use.24,54 The com-
munity pharmacy setting has unique benefits in reaching 
a population unlikely to present for treatment, but one 
where people who are unwilling to discuss their use of 
alcohol can easily transfer their custom to another phar-
macy. Nevertheless, the prevalence of risky alcohol use 
internationally means that increasing the number of people 
receiving SBI, including in novel settings, needs to be a 
public health priority. Furthermore, health authorities are 
now commissioning community pharmacies to undertake 
alcohol interventions.99 Therefore, it is essential that any 
concerns about their effectiveness are resolved before they 
are routinely implemented to ensure that scare health funds 
are not wasted.
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